Latest filing published 08 Mar 2021 for Decibel Therapeutics, Inc..
No signal scores available.
All filings by Adveq Technology IX S.C.S. Schroder on record concern Decibel Therapeutics, Inc. Activity is concentrated on a single trading day, 17 February 2021, with 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 8 March 2021: a transaction, in Decibel Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations